Seegene and Molzym partner on automated molecular sepsis diagnostics
Seegene and Molzym announced a partnership on the automated Magicplex™ sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens.
"The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapid and cost-effective sepsis diagnosis," said Dr. Jong-Yoon Chun, chief executive officer of Seegene. "In treating sepsis, time and accuracy are demanded. Every hour of delay in giving patients the correct antibiotics results in an 8% increase in the mortality rate."
“The automation reduces the total process costs significantly and makes Magicplex Sepsis Test the first true routine sepsis test worldwide” says Prof. Dr. Michael Lorenz, Chief Scientific Officer at Molzym.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
"Why Do We Have Such (Over-) Large Appetites?" : SCIENION AG and Partners Aspire to Appetite Brake - Biotech company from Berlin developing adiposity chip/Nutrigenome Research project alliance analysing genetic factors of obesity
A secreted signature of aging cells
Haldane's_dilemma
Stevia
Agilent Technologies acquires raman spectroscopy innovator

Bayer: Challenging third quarter - Group sales decrease by 5.1 percent (Fx & portfolio adj.) to 8.506 billion euros
Indian_gooseberry
